Related Experiment Video
Updated: Dec 23, 2025
10:17
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
7.3K
Atherogenic dyslipidemia and diabetic nephropathy
Giuseppina Russo1, Pamela Piscitelli2, Annalisa Giandalia1
1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Journal of Nephrology
|April 25, 2020
Summary
Hyperlipidemia, particularly high triglycerides and low HDL cholesterol, may drive diabetic kidney disease (DKD) onset and progression, not just result from it. Improving these lipid levels shows potential for better renal outcomes in type 2 diabetes.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) involves altered lipid metabolism and accumulation.
- Hyperlipidemia is increasingly recognized as a contributor to kidney disease onset and progression, especially in diabetes.
Purpose of the Study:
- To review evidence linking hyperlipidemia to diabetic kidney disease (DKD).
- To examine the role of hypertriglyceridemia and low HDL-cholesterol in DKD.
- To discuss findings from observational studies and clinical trials on lipid management in DKD.
Main Methods:
- Review of recent observational studies on lipid profiles and kidney disease.
- Analysis of randomized clinical trials in type 2 diabetic patients focusing on lipid-lowering interventions and renal outcomes.
- Discussion of proposed biological mechanisms connecting dyslipidemia and kidney damage.
Main Results:
- Observational data suggest glucose control alone is insufficient; hypertriglyceridemia and low HDL-cholesterol are implicated in DKD development and progression.
- Clinical trials investigating drug-induced improvements in hypertriglyceridemia in type 2 diabetes patients are presented.
- Evidence points towards specific lipid abnormalities contributing significantly to renal damage.
Conclusions:
- Hyperlipidemia, specifically hypertriglyceridemia and low HDL-cholesterol, plays a crucial role in the pathogenesis of diabetic kidney disease.
- Targeting these lipid abnormalities may offer a therapeutic strategy to improve renal outcomes in patients with type 2 diabetes.
- Further research into the mechanisms linking dyslipidemia and kidney disease is warranted.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
465
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
465
01:30Peripheral Artery Disease I: Introduction
223
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
223
01:24Nephrotic Syndrome I : Introduction
404
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
404
01:30Coronary Artery Disease I: Introduction
781
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781
01:30Atherosclerosis I: Introduction
662
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
662
01:26Coronary Artery Disease II: Pathophysiology
291
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
291